6505--RX - PYLARIFY (PIFLUFOLASTAT F 18 INJECTION) (NDC 71258-0022-01)
ID: 36C24226Q0246Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF242-NETWORK CONTRACT OFFICE 02 (36C242)ALBANY, NY, 12208, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/workspace/contract/opp/1c1a84144f1f45d385f3f8020334f877/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking sources for the procurement of Pylarify (Piflufolastat F 18 Injection), a radiopharmaceutical injection, to be delivered to VISN 2 Downstate Hospitals. This Sources Sought Notice aims to identify potential large and small businesses, including manufacturers and distributors, capable of providing functionally equivalent products. The procurement is essential for the VA's medical supply needs, particularly in the context of radiopharmaceutical applications in patient care. Interested parties must submit their responses, including firm details and contact information, via email to Aleta Jennette at Aleta.Jennette@va.gov by January 12, 2026, at 10 AM Eastern Time.

    Point(s) of Contact
    Aleta JennetteContracting Officer
    (914) 737-4400 ext 2068
    Aleta.Jennette@va.gov
    Files
    Title
    Posted
    36C24226Q0246.docx
    The Department of Veterans Affairs (VA) Network Contracting Office 2 issued a Sources Sought Notice (Solicitation Number 36C24226Q0246) for RX - PYLARIFY (PIFLUFOLASTAT F 18 INJECTION) (NDC 71258-0022-01). The purpose of this notice is to identify potential sources for this radiopharmaceutical injection. The response deadline is January 12, 2026, at 10 AM Eastern Time. The contracting office is located in Bronx, NY, and the place of performance is VISN 2 Downstate Hospitals in the United States. Aleta Jennette is the point of contact. This notice, with a NAICS code of 325412, is part of the VA's effort to secure necessary medical supplies.
    Sources Sought Template.pdf
    This Sources Sought Notice from the Department of Veterans Affairs (VA) is for market research purposes, seeking interest and capabilities from potential large and small businesses, including manufacturers and distributors, for functionally equivalent radiopharmaceuticals, specifically Pylarify Piflufolastat F 18 Injection (NDC 71258-0022-01). The VA intends to procure these radiopharmaceuticals for delivery to VISN 2 Downstate Hospitals. This is not a solicitation or an obligation to issue one, and the government will not pay for submitted information. The applicable NAICS code is 325412 (Pharmaceutical Preparation Manufacturing). Responses, including firm name, socio-economic category, address, and contact information, are due via email to Aleta.Jennette@va.gov or GSA E-buy.
    Lifecycle
    Title
    Type
    6505--RX - PYLARIFY (PIFLUFOLASTAT F 18 INJECTION) (NDC 71258-0022-01)
    Currently viewing
    Sources Sought
    Similar Opportunities
    6505--Radiopharmaceuticals
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 01, intends to enter into a sole source procurement with Cardinal Health, Inc. for the provision of radiopharmaceutical products to support the VA Manchester Healthcare System in Manchester, NH. The contractor is required to deliver a range of radiopharmaceuticals, including FDG doses and various isotopes, with specific turnaround times and delivery commitments to meet the healthcare needs of veterans. This procurement is critical for ensuring timely access to essential nuclear medicine and PET radiopharmaceuticals, which are vital for patient care. Interested parties that believe they can fulfill these requirements must submit their capabilities in writing by November 26, 2025, to Jerry Choinski at jerry.choinski@va.gov.
    6505--Radiopharmaceuticals
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, Network Contracting Office 01, intends to award a sole source contract to Pharmalogic LTD for the provision of radiopharmaceuticals to support the Veterans Affairs Medical Center (VAMC) in White River Junction, Vermont. The contractor is required to supply USDA and USP-approved radiopharmaceuticals, including specific products such as Kinevac and TC-99M DTPA, on an as-needed basis, with a commitment to provide 24/7 ordering and delivery services, typically involving two deliveries per day. This procurement is critical for the VAMC's nuclear medicine operations, ensuring timely access to essential medical supplies for patient care. Interested parties capable of fulfilling these requirements must submit their capabilities in writing by December 31, 2025, at 4 PM EST, to Jerry Choinski at jerry.choinski@va.gov.
    Radiopharmaceuticals for Temple Texas VA Medical Center
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a contractor to provide radiopharmaceuticals for the Olin E. Teague VA Medical Center in Temple, Texas, through a short-term contract lasting six months. This procurement is critical for the Nuclear Medicine Department, as the radiopharmaceuticals are essential for medical imaging and therapeutic treatments for various carcinomas, with a total estimated procurement cost of $445,000. The urgency of this requirement is underscored by the short shelf-life of the products, necessitating timely delivery to ensure continuous patient care for veterans. Interested vendors can contact Jeffrey Crysler at jeffrey.crysler@va.gov or by phone at 210-617-5300 for further details.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking information from domestic pharmaceutical manufacturers through a Request for Information (RFI) designated 36C77026Q0061, aimed at supporting the Consolidated Mail Outpatient Pharmacy (CMOP) in fulfilling its Open Market (OM) purchasing needs. The RFI seeks to identify both small and large businesses capable of providing a range of pharmaceutical products and ancillary items, with a focus on those manufactured in the United States, to enhance the supply chain for approximately 450,000 prescriptions mailed daily to Veterans. Interested manufacturers are required to submit detailed company and product information, including FDA-approved NDC numbers and operational capabilities, by March 15, 2026, at 4:30 PM CT. For further inquiries, respondents can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.
    Radiology & Imaging FY2025 Solicitation
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is issuing a Request for Proposal (RFP) for the procurement of Radiology Imaging Systems and Accessories, under solicitation number 36H79725R0003. This opportunity encompasses a five-year base period with an option for an additional five years, aiming to establish multiple Indefinite Delivery/Indefinite Quantity (IDIQ) contracts valued at approximately $6.5 billion over ten years, supporting both the VA and the Department of Defense. The solicitation includes detailed requirements for imaging modalities, compliance with DICOM standards, and contractor responsibilities for training and product support, with proposals due by February 3, 2026. Interested vendors should direct inquiries to LaTonya Whiteside at LaTonya.Whiteside@va.gov by December 18, 2025, to ensure clarity in their submissions.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    NX EQ Laparoscopic Insufflators
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify qualified vendors capable of supplying brand name or equal Olympus Laparoscopic Insufflators and associated equipment for the Veterans Health Administration (VHA) on an agency-wide basis. The procurement aims to establish a single Requirements Contract with Firm-Fixed Price (FFP) orders, anticipated to include a 12-month base period and four additional 12-month option periods. These laparoscopic insufflators are critical for various surgical procedures, enhancing the capabilities of the VHA in providing quality healthcare to veterans. Interested vendors must submit their responses by January 5, 2026, at 9:00 AM EST, via email to Trevor Mason at Trevor.Mason@va.gov and Sara Vickroy at Sara.Vickroy@va.gov, and must be registered in SAM.gov to participate.
    6505--766-26-1-400-0207 -Charleston CMOP 2 Pharmaceuticals -(VA-26-00025368)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking to procure two specific pharmaceuticals, JASMIEL (J0040) 28-DAY TABLET and DROSPIRENONE 4MG (D1217), for the Consolidated Mail Outpatient Pharmacy (CMOP) in Ladson (Charleston). This procurement is critical as the products have been prescribed by VA physicians, and no substitutions are permitted due to the absence of alternative suppliers in the market. Vendors are required to submit a signed SF1449, a completed pricing schedule, a valid State Wholesale Distributor License, and a Buy American Act Certificate by January 5, 2026, at 3:00 PM CT, with deliveries staggered over a six-month period starting ten days after order receipt. Interested parties should direct their quotes to Kelley Cunningham at kelley.cunningham@va.gov.
    Y90 SIR Spheres
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure Y-90 SIR Spheres microspheres for use in Selective Internal Radiation Therapy (SIRT) at the North Texas Medical Center in Dallas, Texas. This contract involves the purchase of five unit doses of Sie-Spheres Y90 resin microspheres, estimated at $17,750 per dose, to ensure the availability of this critical treatment for patients with liver tumors. The unique characteristics of these microspheres, provided solely by Sirtex Medical, are essential for delivering targeted radiation therapy, as they are designed to lodge in tumor arterioles while minimizing exposure to healthy tissue. Interested parties can contact Contract Specialist Robert Clark at robert.clark15@va.gov or by phone at 512-228-1088 for further details regarding this procurement, which is justified under FAR 13.106-1 and is expected to exceed the micro-purchase threshold but remain under the simplified acquisition threshold of $250,000.